Related Experiment Video
Updated: Sep 30, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
687
Long noncoding RNA polymorphisms and colorectal cancer risk: Progression and future perspectives
Esmat Abdi1, Saeid Latifi-Navid1, Hamid Latifi-Navid2
1Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.
Environmental and Molecular Mutagenesis
|March 11, 2022
Summary
This study investigates how long noncoding RNA (lncRNA) genetic variations, specifically single nucleotide polymorphisms (SNPs), impact colorectal cancer (CRC) risk and outcomes. Findings could improve personalized cancer risk prediction and therapy.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- Long noncoding RNAs (lncRNAs) play roles in cancer, acting as oncogenes or tumor suppressors.
- lncRNA polymorphisms, like single nucleotide polymorphisms (SNPs), may influence cancer risk and treatment.
Purpose of the Study:
- To investigate the association between lncRNA polymorphisms and colorectal cancer (CRC) risk.
- To explore the potential clinical and therapeutic implications of these lncRNA variations in CRC patients.
Main Methods:
- This research focuses on analyzing the relationship between specific genetic variations within lncRNAs and CRC.
- The study aims to evaluate how these polymorphisms affect an individual's susceptibility to CRC.
- Potential impacts on disease progression and treatment response are also considered.
Main Results:
- The study assesses how single nucleotide polymorphisms (SNPs) in lncRNAs can alter their function.
- SNPs may directly affect lncRNA expression or indirectly influence regulatory factors.
- Disruption of lncRNA interactions with other molecules by SNPs is examined.
Conclusions:
- lncRNA polymorphisms represent potential biomarkers for CRC risk assessment.
- Further research is needed to validate these findings in diverse populations for personalized medicine.
- Understanding SNP effects on lncRNAs could lead to novel therapeutic strategies for colorectal cancer.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
03:18Non-LTR Retrotransposons
12.0K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:05Single Nucleotide Polymorphisms-SNPs
16.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.2K